Cross-subtype antibody and cellular immune responses induced by a polyvalent DNA prime–protein boost HIV-1 vaccine in healthy human volunteers-Reference-Cited by-同舟云学术

Cross-subtype antibody and cellular immune responses induced by a polyvalent DNA prime–protein boost HIV-1 vaccine in healthy human volunteers

Published:2008-02 Issue:8 Volume:26 Page:1098-1110
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Wang Shixia,Kennedy Jeffrey S.,West Kim,Montefiori David C.,Coley Scott,Lawrence John,Shen Siyuan,Green Sharone,Rothman Alan L.,Ennis Francis A.,Arthos James,Pal Ranajit,Markham Phillip,Lu Shan

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference48 articles.

1. HIV/AIDS JUNPo. Report on the global AIDS epidemic 2006. 2006 [cited 2007 14 February]; Availablefrom: http://data.unaids.org/pub/GlobalReport/2006/2006_GR_CH02_en.pdf.

2. HIV-1MN recombinant glycoprotein 160 vaccine-induced cellular and humoral immunity boosted by HIV-1MN recombinant glycoprotein 120 vaccine. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group;Gorse;AIDS Res Hum Retroviruses,1999

3. Specific antibody responses to vaccination with bivalent CM235/SF2 gp120: detection of homologous and heterologous neutralizing antibody to subtype E (CRF01.AE) HIV type 1;Kim;AIDS Res Hum Retroviruses,2003

4. Vaccine-induced antibodies to the native, oligomeric envelope glycoproteins of primary HIV-1 isolates;Lee;Vaccine,2001

5. A phase I/II trial of HIV SF2 gp120/MF59 vaccine in seronegative thais. AFRIMS-RIHES Vaccine Evaluation Group. Armed Forces Research Institute of Medical Sciences and the Research Institute for Health Sciences;Nitayaphan;Vaccine,2000

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revisiting the dimensions of universal vaccine with special focus on COVID-19: Efficacy versus methods of designing;International Journal of Biological Macromolecules;2024-10

2. A broad-spectrum multiepitope vaccine against seasonal influenza A and B viruses in mice;eBioMedicine;2024-08

3. Human CD4-binding site antibody elicited by polyvalent DNA prime-protein boost vaccine neutralizes cross-clade tier-2-HIV strains;Nature Communications;2024-05-21

4. Safety and immunogenicity of a polyvalent DNA–protein HIV vaccine with matched Env immunogens delivered as a prime–boost regimen or coadministered in HIV-uninfected adults in the USA (HVTN 124): a phase 1, placebo-controlled, double-blind randomised controlled trial;The Lancet HIV;2024-05

5. Heterologous DNA Prime/Protein Boost Immunization Targeting Nef-Tat Fusion Antigen Induces Potent T-cell Activity and in vitro Anti-SCR HIV-1 Effects;Current HIV Research;2024-03